Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinjection over a 1-year period: the CoSa study
Academic Article
Publication Date:
2008
Short description:
Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinjection over a 1-year period: the CoSa study / Lugaresi, A., Durastanti, V., Gasperini, C., Lai, M., Pozzilli, C., Orefice, G., Sotgiu, S., Pucci, E., Ardito, B., Millefiorini, E., the CoSa Study, G.. - In: CLINICAL NEUROPHARMACOLOGY. - ISSN 0362-5664. - 31:3(2008), pp. 167-172. [10.1097/wnf.0b013e3181571a8e]
Iris type:
1.1 Articolo in rivista
List of contributors:
Lugaresi, A.; Durastanti, V.; Gasperini, C.; Lai, M.; Pozzilli, C.; Orefice, G.; Sotgiu, Stefano; Pucci, E.; Ardito, B.; Millefiorini, E.; the CoSa Study, Group
Published in: